Heru Wins Prestigious CES Innovation Award for 2nd Consecutive Year with Expanded, Multimodal Platform November 17, 2022
Heru Continues to Revolutionize Vision Care, Surpassing Clinical Milestone of 100,000 Eyes Examined November 14, 2022
Heru’s Wearable Diagnostic, Health and Wellness Platform Honored with Prestigious CES Innovation Award by the Consumer Technology Association (CTA) November 19, 2021
Heru Transforms the Future of Eye Care with the Release of re:Vive 2.0: A Single Wearable Platform with 6 Vision Diagnostic Modalities that Support 5 CPT Codes November 9, 2021
Study Shows Heru’s Automated Visual Field Testing Platform Delivers Strong Correlation to Humphrey Field Analyzer September 22, 2021
Heru, the Wearable Diagnostic and Vision Augmentation Leader, Launches Commercial Availability of re:Vive in Partnership with Vision Source August 5, 2021
Heru, the Wearable Diagnostic and Vision Augmentation Leader, Bolsters Executive Team with Seasoned Industry Veterans July 13, 2021
Heru Series A Funding Accelerates Cloud and Artificial Intelligence-Enabled Wearable Vision Diagnosis and Therapy May 20, 2021
Medical Technology Company Heru, Inc. Completes FDA Registration Following a $2.7M Seed Round December 21, 2020
